SOPHIA ANTIPOLIS, France, December 23 NicOxS.A. (NYSE Euronext Paris: COX) today announced the results of a phase 2astudy for TPI 1020, conducted in 62 patients with Chronic ObstructivePulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results